Skip to main content
Premium Trial:

Request an Annual Quote

ZPredicta, LabCorp Form Cancer Cell Culture Model Partnership

NEW YORK — ZPredicta said on Thursday that it has partnered with Laboratory Corporation of America to develop and commercialize tumor-specific preclinical models based on its 3D cell culture platform.

ZPredicta's platform integrates organ-specific cellular and extracellular elements into 3D culture models for in vitro cancer drug testing. The San Jose, California-based company said that the alliance with LabCorp will help expand the platform's use for preclinical testing and research studies.

Specific terms of the deal were not disclosed.

"LabCorp is one of the world’s leading life science companies and its drug development business, Covance, is one of the leading end-to-end development partners for the biopharmaceutical industry," ZPredicta Founder and CEO Julia Kirshner said in a statement. "With this strategic relationship, we are well positioned to offer our cell culture technology to a much larger customer base and also to expand the number of cell culture models that we offer."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.